Does Metabolic and Bariatric Surgery Reduce the Risk of Developing Parkinson’s Disease: A Propensity Score Matching Analysis Using Data from the National Inpatient Sample - Scorecard - MDSpire
Advertisement
Does Metabolic and Bariatric Surgery Reduce the Risk of Developing Parkinson’s Disease: A Propensity Score Matching Analysis Using Data from the National Inpatient Sample
Clinical Scorecard: Impact of Metabolic and Bariatric Surgery on Parkinson’s Disease Risk: Analysis Utilizing Propensity Score Matching from National Inpatient Sample Data
At a Glance
Category
Detail
Condition
Obesity and Parkinson’s disease
Key Mechanisms
Metabolically unhealthy obesity increases Parkinson’s disease risk via associated medical problems; MBS may provide neuroprotection through gut-brain axis modulation and enhanced dopamine bioavailability
Target Population
People with obesity, including those undergoing metabolic and bariatric surgery
Care Setting
Inpatient hospital settings across the United States
Key Highlights
Metabolically unhealthy obesity significantly elevates Parkinson’s disease risk, while metabolically healthy obesity may be neuroprotective.
Metabolic and bariatric surgery (MBS) effectively reduces obesity-related medical problems and may reduce Parkinson’s disease risk.
Propensity score-matched analysis of 2018–2019 US National Inpatient Sample data compared Parkinson’s disease prevalence in obese patients with and without MBS.
Guideline-Based Recommendations
Diagnosis
Use ICD-10 codes to identify obesity and Parkinson’s disease types (primary G20, secondary G21).
Assess associated medical problems using Elixhauser comorbidity measures.
Management
Consider metabolic and bariatric surgery for sustained weight loss and reduction of metabolic syndrome in obese patients.
Monitor for potential neuroprotective effects of MBS in patients at risk for Parkinson’s disease.
Monitoring & Follow-up
Follow demographic and clinical characteristics post-MBS to evaluate changes in Parkinson’s disease prevalence.
Use propensity score matching to adjust for confounders in observational data.
Risks
Be aware of differences in comorbidities pre- and post-MBS, including depression and hypothyroidism prevalence.
Monitor mortality rates, which were lower in the MBS group compared to non-MBS.
Patient & Prescribing Data
Hospitalized patients with obesity in the United States (2018–2019), including those with and without history of MBS
MBS patients showed lower prevalence of several obesity-related complications and lower mortality; MBS may be associated with reduced Parkinson’s disease risk after adjusting for confounders.
Clinical Best Practices
Utilize large inpatient databases and propensity score matching to assess treatment effects in observational studies.
Incorporate comprehensive covariate adjustment including demographic, clinical, and hospital characteristics.
Recognize the bidirectional relationship between obesity and Parkinson’s disease when managing patients.
